About this trial

Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).

Eligibility criteria

Qualifiers

patients admitted to the pediatric intensive care unit or cardiac intensive care unit

patient age : 1,8 kg-15 years

patient receiving antibiotic treatment (piperacillin-tazobactam, meropenem, amoxicillin-clavulanate, cephazolin, vancomycin, teicoplanin, ciprofloxacin, amikacin)

intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)

Disqualifiers

no catheter in place for blood sampling

absence of parental/patient consent

known hypersensitivity to beta-lactam antibiotics and ciprofloxacin

Trial design

Treatments tested in this trial

  • Amoxicillin-clavulanate
  • Piperacillin-tazobactam
  • Meropenem
  • Cefazolin
  • Vancomycin
  • Teicoplanin
  • Ciprofloxacin
  • Amikacin

Treatment groups

300 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Locations

3
Queen Fabiola Children's University Hospital1020, BrusselsBrussels Capital, Belgium
University Hospital9000, Ghent Belgium
Universitair hospital3000, Leuven Belgium

Sponsors and collaborators

University Hospital, Ghent

Lead sponsor